Atypical hemolytic uremic syndrome
aHUS · Rare Disease · 2 drugs · 1 indications
Complement-mediated thrombotic microangiopathy.
Competitive Landscape (2 drugs)
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|
| Soliris | AZN | C5 inhibitor | Antibody | IV | APPROVED |
| Ultomiris | AZN | C5 inhibitor | Antibody | IV | APPROVED |
Indications (1)
Atypical hemolytic uremic syndrome
Upcoming Catalysts
Ultomiris - IgAN - Ph3 - Topline (ICAN)CLINICAL
AZNH1 2026
Ultomiris - HSCT-TMA - Ph3 - ToplineCLINICAL
AZNH1 2026
Data from Supabase · Updated 2026-03-24